Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Lefkowith

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|July 1, 1994
Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in ratX Wu, A J Wittwer, L S Carr, et al.
The Journal of Clinical Investigation|September 15, 1996
Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosusJ B Lefkowith, M Kiehl, J Rubenstein, et al.
The Journal of Experimental Medicine|April 1, 1996
Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNAG S Gilkeson, P Ruiz, A M Pippen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1996
Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular featuresJ B Lefkowith, R Di Valerio, J Norris, et al.
The Journal of International Medical Research|January 24, 2002
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hipA J Kivitz, R W Moskowitz, E Woods, et al.
Clinical Immunology and Immunopathology|July 1, 1995
The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodiesG S Gilkeson, K Bernstein, A M Pippen, et al.
Clinical Therapeutics|January 23, 1999
Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritisL S Simon, S Z Zhao, L M Arguelles, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|July 1, 1994
Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in ratX Wu, A J Wittwer, L S Carr, et al.
The Journal of Clinical Investigation|September 15, 1996
Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosusJ B Lefkowith, M Kiehl, J Rubenstein, et al.
The Journal of Experimental Medicine|April 1, 1996
Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNAG S Gilkeson, P Ruiz, A M Pippen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1996
Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular featuresJ B Lefkowith, R Di Valerio, J Norris, et al.
The Journal of International Medical Research|January 24, 2002
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hipA J Kivitz, R W Moskowitz, E Woods, et al.
Clinical Immunology and Immunopathology|July 1, 1995
The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodiesG S Gilkeson, K Bernstein, A M Pippen, et al.
Clinical Therapeutics|January 23, 1999
Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritisL S Simon, S Z Zhao, L M Arguelles, et al.
JAMA|September 9, 2000
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyF E Silverstein, G Faich, J L Goldstein, et al.
Pageof 6